Non-CSD melanomas develop typically in younger patients and predominantly carry BRAF mutations, while CSD melanomas have a higher mutation burden, more often contain NF1, NRAS or KIT mutations and affect older people at the distal extremities and head and neck region [5,6]. This evidence concerns the gene KIT and melanoma.